Browsing by Author Perez, E. A.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2014Adjuvant exemestane with ovarian suppression in premenopausal breast cancerCoates, Alan; Burstein, Harold J.; Colleoni, Marco; et al, Various; Fleming, G. F.; Gomez, Henry; Lang, Istvan; Pagani, Olivia; Perez, E. A.; Regan, Meredith M.; Tondini, Carlo; Walley, B; School of Public Health: Public HealthAdjuvant exemestane with ovarian suppression in premenopausal breast cancer, New England Journal of Medicine, vol.371, 2, 2014,pp 107-118
2014Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete responseBoyle, Frances; Barrios, Carlos; De Azambuja, Evandro; Di Cosimo, Serena; et al, Various; Holmes, Andrew P; Holmes, Eileen; Jackisch, Christian; Lang, Istvan; Perez, E. A.; Piccart-Gebhart, Martine; Smith, Ian (Prof); Swaby, Ramona F; Untch, Michael; Xu, Binghe; Northern Clinical School: MedicineLapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response, The Lancet Oncology, vol.15, 10, 2014,pp 1137-1146
2008Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?Coates, Alan; et al, Various; Fleming, G. F.; Francis, P A; Pagani, Olivia; Perez, E. A.; Price, K N; Regan, Meredith M.; Thurlimann, Beat; Torrisi, R; Walley, B; School of Public Health: Public HealthPremenopausal endocrine-responsive early breast cancer: who receives chemotherapy?, Annals of Oncology, vol.19, 7, 2008,pp 1231-1241